T1	chemical 25 34	antigenic
T2	chemical 35 43	epitopes
T3	disease_or_phenotypic_feature 52 60	melanoma
T4	chemical 81 88	antigen
T5	disease_or_phenotypic_feature 167 182	Pulmonary edema
T6	chemical 199 213	methylene blue
T7	chemical 214 217	dye
T8	chemical 273 287	mTOR inhibitor
T9	disease_or_phenotypic_feature 307 328	Merkel cell carcinoma
T10	chemical 330 333	MCC
T11	chemical 359 368	Vitamin D
T12	disease_or_phenotypic_feature 399 406	obesity
T13	disease_or_phenotypic_feature 459 466	obesity
T14	chemical 475 485	biomarkers
T15	chemical 509 517	nitrogen
T16	disease_or_phenotypic_feature 535 556	chronic renal failure
T17	disease_or_phenotypic_feature 561 574	short stature
T18	chemical 606 620	growth hormone
T19	disease_or_phenotypic_feature 633 664	secondary adrenal insufficiency
T20	disease_or_phenotypic_feature 666 680	hypothyroidism
T21	disease_or_phenotypic_feature 685 714	hypogonadotropic hypogonadism
T22	disease_or_phenotypic_feature 742 750	diabetes
T23	disease_or_phenotypic_feature 755 762	obesity
T24	chemical 774 778	food
T25	chemical 779 786	balance
T26	disease_or_phenotypic_feature 868 874	glioma
T27	chemical 910 915	probe
T28	disease_or_phenotypic_feature 937 943	glioma
T29	disease_or_phenotypic_feature 966 973	obesity
T30	chemical 977 983	oxygen
T31	disease_or_phenotypic_feature 1014 1025	sleep apnea
T32	disease_or_phenotypic_feature 1035 1043	syndrome
T33	chemical 1046 1055	Mitomycin
T34	chemical 1057 1073	cyclophosphamide
T35	chemical 1079 1088	cisplatin
T36	disease_or_phenotypic_feature 1210 1222	growth delay
T37	chemical 1260 1270	vancomycin
T38	chemical 1289 1297	solution
T39	disease_or_phenotypic_feature 1312 1320	cataract
T40	chemical 1374 1380	cobalt
T41	chemical 1395 1400	metal
T42	disease_or_phenotypic_feature 1450 1458	tinnitus
T43	disease_or_phenotypic_feature 1460 1468	deafness
T44	disease_or_phenotypic_feature 1470 1477	vertigo
T45	disease_or_phenotypic_feature 1495 1508	optic atrophy
T46	disease_or_phenotypic_feature 1521 1542	peripheral neuropathy
T47	chemical 1563 1570	antigen
T48	disease_or_phenotypic_feature 1592 1610	prostate carcinoma
T49	chemical 1622 1632	anesthesia
T50	disease_or_phenotypic_feature 1637 1645	cataract
T51	chemical 1698 1705	hormone
T52	chemical 1711 1719	cortisol
T53	disease_or_phenotypic_feature 1723 1729	autism
T54	disease_or_phenotypic_feature 1752 1759	obesity
T55	disease_or_phenotypic_feature 1764 1771	obesity
T56	chemical 1841 1850	nutrients
T57	chemical 1860 1867	calcium
T58	chemical 1869 1873	iron
T59	chemical 1878 1887	potassium
T60	disease_or_phenotypic_feature 1918 1925	obesity
T61	chemical 1956 1960	1-7)
T62	chemical 1966 1974	agonists
T63	chemical 1982 1986	drug
T64	disease_or_phenotypic_feature 2011 2018	obesity
T65	disease_or_phenotypic_feature 2050 2059	cleft lip
T66	disease_or_phenotypic_feature 2064 2076	cleft palate
T67	chemical 2119 2127	ketamine
T68	chemical 2128 2138	anesthesia
T69	chemical 2140 2149	Tepoxalin
T70	chemical 2167 2176	inhibitor
T71	chemical 2181 2190	erlotinib
T72	chemical 2199 2208	inhibitor
T73	disease_or_phenotypic_feature 2230 2244	gastric cancer
T74	chemical 2282 2288	sodium
T75	chemical 2289 2298	potassium
T76	disease_or_phenotypic_feature 2336 2357	neurological diseases
T77	disease_or_phenotypic_feature 2380 2388	Dystonia
T78	disease_or_phenotypic_feature 2446 2449	AHC
T79	disease_or_phenotypic_feature 2455 2472	Cerebellar ataxia
T80	disease_or_phenotypic_feature 2496 2509	Optic atrophy
T81	disease_or_phenotypic_feature 2514 2540	Sensorineural hearing loss
T82	disease_or_phenotypic_feature 2549 2557	syndrome
T83	corrected_chemical 199 217	methylene blue dye
R1	causes_or_contributes_to Arg1:T83 Arg2:T5	
T84	missed_chemical 288 295	MLN0128
T85	missed_disease_or_phenotypic_feature 330 333	MCC
R3	treats Arg1:T84 Arg2:T85	
R5	treats Arg1:T84 Arg2:T9	
T86	missed_disease_or_phenotypic_feature 1112 1124	tumor growth
R6	treats Arg1:T35 Arg2:T86	
R7	treats Arg1:T34 Arg2:T86	
R8	treats Arg1:T33 Arg2:T86	
R9	causes_or_contributes_to Arg1:T40 Arg2:T42	
R10	causes_or_contributes_to Arg1:T40 Arg2:T43	
R11	causes_or_contributes_to Arg1:T40 Arg2:T44	
R12	causes_or_contributes_to Arg1:T40 Arg2:T45	
R13	causes_or_contributes_to Arg1:T40 Arg2:T46	
T87	missed_disease_or_phenotypic_feature 1479 1493	visual changes
T88	missed_disease_or_phenotypic_feature 1510 1516	tremor
R14	causes_or_contributes_to Arg1:T40 Arg2:T87	
R15	causes_or_contributes_to Arg1:T40 Arg2:T88	
T89	corrected_chemical 1943 1974	(Angiotensin-1-7)-like agonists
R16	treats Arg1:T89 Arg2:T64	
R17	treats Arg1:T69 Arg2:T73	
R18	treats Arg1:T71 Arg2:T73	
T90	corrected_chemical 2152 2176	dual 5-LOX-COX inhibitor
T91	corrected_chemical 2194 2208	EGFR inhibitor
R19	treats Arg1:T91 Arg2:T73	
R20	treats Arg1:T90 Arg2:T73	
T92	corrected_chemical 268 287	Dual mTOR inhibitor
R2	treats Arg1:T92 Arg2:T9	
R4	treats Arg1:T92 Arg2:T85	
R21	causes_or_contributes_to Arg1:T41 Arg2:T42	
R22	causes_or_contributes_to Arg1:T41 Arg2:T43	
R23	causes_or_contributes_to Arg1:T41 Arg2:T44	
R24	causes_or_contributes_to Arg1:T41 Arg2:T87	
R25	causes_or_contributes_to Arg1:T41 Arg2:T45	
R26	causes_or_contributes_to Arg1:T41 Arg2:T46	
R27	causes_or_contributes_to Arg1:T41 Arg2:T88	
R28	treats Arg1:T63 Arg2:T64	
T93	missed_disease_or_phenotypic_feature 1178 1198	increase in lifespan
T94	corrected_disease_or_phenotypic_feature 1204 1222	tumor growth delay
R29	causes_or_contributes_to Arg1:T35 Arg2:T94	
R30	causes_or_contributes_to Arg1:T35 Arg2:T93	
R31	causes_or_contributes_to Arg1:T34 Arg2:T94	
R32	causes_or_contributes_to Arg1:T34 Arg2:T93	
R33	causes_or_contributes_to Arg1:T33 Arg2:T93	
R34	causes_or_contributes_to Arg1:T33 Arg2:T94	
R35	treats Arg1:T56 Arg2:T54	
R36	treats Arg1:T57 Arg2:T54	
R37	treats Arg1:T58 Arg2:T54	
R38	treats Arg1:T59 Arg2:T54	
T95	corrected_disease_or_phenotypic_feature 1764 1792	obesity related health risks
R39	treats Arg1:T56 Arg2:T95	
R40	treats Arg1:T57 Arg2:T95	
R41	treats Arg1:T58 Arg2:T95	
R42	treats Arg1:T59 Arg2:T95	
